期刊文献+

血清骨保护素和糖化血红蛋白水平与急性冠状动脉综合征的关系探讨

Relationship between serum osteoprotegerin and glycated hemoglobin levels in patients with acute coronary syndrome
下载PDF
导出
摘要 目的:探讨血清骨保护素(OPG)和糖化血红蛋白(HbA1c)水平与急性冠状动脉综合征(ACS)的关系。方法:将88例住院患者分为对照组、稳定性心绞痛(SAP)组和ACS组,于入院时检测3组患者血浆OPG和HbA1c水平并进行冠状动脉造影。根据造影结果分为1支、2支、3支病变组并分析各组与冠状动脉病变Gensini评分的相关性。结果:ACS组患者OPG和HbA1c水平均高于对照组(P<0.01),且随病变支数的增加而升高(P<0.05~P<0.01)。OPG与冠状动脉病变Gensini评分间呈显著正相关关系(P<0.01);HbA1c与冠状动脉病变Gensini评分也呈正相关关系(P<0.01)。OPG与HbA1c呈显著正相关关系(P<0.01)。结论:血清OPG和HbA1c水平的升高与ACS病变程度有关。 Objective: To analyze the relationship between serum osteoprotegerin(OPG) and glycated hemoglobin(HbA1c) levels in patients with acute coronary syndrome(ACS).Methods: Eighty-eight patients were classified into control group,stable angina pectoris(SAP) group and ACS group.Serum OPG and HbA1c levels were measured upon hospital admission and divided into 1-,2-,3-vessel disease groups according to the numbers of narrowed coronary vessels under coronary angiography.The relationships of serum OPG and HbA1c levels and coronary stenosis degree according to Gensini score were analyzed.Results: Serum OPG and HbA1c levels in ACS group were significantly higher than in control group(P 0.01),and OPG and HbA1c levels were increased significantly with the severity degree of ACS(P 0.05-P 0.01).A positive relationship was found between OPG level and Gensini score(P 0.01),and a positive correlation was also found between HbA1c level and Gensini score(P 0.01).OPG level was positively correlated with HbA1c level(P 0.01).Conclusions: Serum OPG and HbA1c levels were related with the severity of ACS.
出处 《蚌埠医学院学报》 CAS 2013年第5期542-544,共3页 Journal of Bengbu Medical College
关键词 急性冠状动脉综合征 骨保护素 糖化血红蛋白 冠状动脉病变程度 acute coronary syndrome osteoprotegerin glycated hemoglobin coronary artery disease severity degree
  • 相关文献

参考文献9

  • 1Secchiero P, Coralina D, Rimondi E, et al. Activation of the p53 pathwaydown-regulates the osteoprotegerin expression and release by vascularendothelial cells [ J ]. Blood, 2008, 111 ( 3 ) : 1287 - 1294.
  • 2Ueda H, Mitsusada N, Harimoto K, et al. Glycosylated hemoglobin is a predictor of major adverse cardiac events after drug-eluting stent implantation in patients with diabetes mellitus [ J ]. Cardiology,2010,116( 1 ) :51 -57.
  • 3Morony S ,Tintut Y, Zhang Z ,et al. Osteoprotegerin inhibitsvascular cal-cification without affecting atherosclerosis in ldlrmice [ J ]. Circulation ,2008,117 ( 3 ) :411 - 420.
  • 4AvignonA, Sultan A, Plot C, et al. Osteoprotegerin is associated withsilent coronary artery disease in high-risk butasymptomatic type 2 diabeticpatients [ J]. Diabetes Care ,2005,28 (9) :2176 - 2180.
  • 5Ren MY, Sui SJ, Zhang Y, et al. Increased plasma osteeoprotegerinlevels are associated with the presence and severity of acute coronarysyndrome [ J 1. Acta Cardio, 2008, 63(5) :615 -622.
  • 6Blankenberg S, Zeller T, Saarela O, et al. Contribution of 30 biomarkers to 10-year cardiovascular risk estimation in 2 population cohorts: the MONICA, risk, genetics, archiving, and monograph(MORGAM) biomarker project[ J]. Circulation,2010, 121 (22) :2388 -2397.
  • 7Melander O, Newton-Cheh C, Almgren P, et aL Novel and conventional biomarkers for prediction of incident cardiovascular events in the community[ J]. JAMA ,2009,302 (1) :49 -57.
  • 8Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score [ J ]. JAMA, 2007, 297(6) :611 -619.
  • 9Calkin AC, Allen TJ. Diabetes mellitus-associatedat herosclerosis: mechanisms involved and potential for pharmacological invention [ J ]. Am J Cardiovasc Drugs,2006,6 ( 1 ) : 15 - 40.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部